Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Keiser

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1983
Sodium-retaining steroids increase parotid salivary kallikreinD Horwitz, D Proud, W J Lawton, et al.
Clinical Chemistry|November 1, 1986
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidaseG Eisenhofer, D S Goldstein, R Stull, et al.
The Journal of Clinical Investigation|July 1, 1985
Measurement of regional neuronal removal of norepinephrine in manD S Goldstein, R Zimlichman, R Stull, et al.
La Radiologia Medica|June 1, 1993
[Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal]S Maurea, A Cuocolo, J C Reynolds, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Effects of restriction of sodium or administration of fludrocortisone on parotid salivary kallikrein in manD Horwitz, D Proud, W J Lawton, et al.
Annals of Internal Medicine|December 1, 1986
Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytomaD S Goldstein, R Stull, G Eisenhofer, et al.
Life Sciences|July 13, 1987
Correlation of changes in cardiac calcium channels with hemodynamics in Syrian hamster cardiomyopathy and heart failureM S Finkel, E S Marks, R E Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Neuropeptide Y expression distinguishes malignant from benign pheochromocytomaL J Helman, P S Cohen, S D Averbuch, et al.
The New England Journal of Medicine|June 11, 1974
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinomaH D Brereton, P V Halushka, R W Alexander, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test resultsGraeme Eisenhofer, David S Goldstein, McClellan M Walther, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
Advances in Experimental Medicine and Biology|January 1, 1983
Sodium-retaining steroids increase parotid salivary kallikreinD Horwitz, D Proud, W J Lawton, et al.
Clinical Chemistry|November 1, 1986
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidaseG Eisenhofer, D S Goldstein, R Stull, et al.
The Journal of Clinical Investigation|July 1, 1985
Measurement of regional neuronal removal of norepinephrine in manD S Goldstein, R Zimlichman, R Stull, et al.
La Radiologia Medica|June 1, 1993
[Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal]S Maurea, A Cuocolo, J C Reynolds, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Effects of restriction of sodium or administration of fludrocortisone on parotid salivary kallikrein in manD Horwitz, D Proud, W J Lawton, et al.
Annals of Internal Medicine|December 1, 1986
Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytomaD S Goldstein, R Stull, G Eisenhofer, et al.
Life Sciences|July 13, 1987
Correlation of changes in cardiac calcium channels with hemodynamics in Syrian hamster cardiomyopathy and heart failureM S Finkel, E S Marks, R E Patterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Neuropeptide Y expression distinguishes malignant from benign pheochromocytomaL J Helman, P S Cohen, S D Averbuch, et al.
The New England Journal of Medicine|June 11, 1974
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinomaH D Brereton, P V Halushka, R W Alexander, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test resultsGraeme Eisenhofer, David S Goldstein, McClellan M Walther, et al.
Pageof 24